Free

Should we give tax breaks to companies developing drugs for rare diseases - Essay Example

Comments (0) Cite this document
Summary
However, because of the miniscule size of afflicted, the companies decline to do so. It will not be financially conducive for them to delve into it because of…
Download full paperFile format: .doc, available for editing
GRAB THE BEST PAPER95.9% of users find it useful
Should we give tax breaks to companies developing drugs for rare diseases
Read TextPreview

Extract of sample "Should we give tax breaks to companies developing drugs for rare diseases"

Should We Give Tax Breaks to Companies Developing Drugs For Rare Diseases? There are minor diseases which get “orphaned” because only a small portion of the worlds population suffers from it. However, because of the miniscule size of afflicted, the companies decline to do so. It will not be financially conducive for them to delve into it because of the small return on investment on something that could cost the company billions of dollars to produce. Which is why the government should offer taxpayer support for the research and development of these drugs. Pretending the illness does not exist, will not magically create a cure for the afflicted. It will only hasten their death. Since it is within the power of the government and tax payers to prevent these deaths by offering tax support, then so be it. After all, they would want the cure if they were afflicted with the minor, yet life threatening illness themselves. Creating an orphan drug is more of a labor of love for these companies because the return on investment is slow. However, the government, under the “Orphan Drug Act” provides tax breaks to companies like Genzyme, who create these kinds of drugs. That tax break alone helps ease the burden of r&d cost for the company. As such, the company can pass on the savings to the patients who do not have to pay unrealistic costs for the drugs because the company can afford to sell the drugs directly to the doctor specialist in almost all cases.
The sentiment against the use of tax money in r&d for orphaned drugs do so under because the actual cost and length of time spent on the development the drug remains unknown and debatable to the tax payers. The taxpayers would rather that the tax money go to subsidizing healthcare for many instead. However, the needs of few will also affect the many because research into orphan drugs sometimes turns up valuable information or advancements for current medical drugs as well. Therefore, it has a payback appeal in a certain way. However, collaboration between small and large pharmaceutical companies is not an option because the big companies will be concentrated on quick ROI and the integration of their current crop of products in the orphaned drug. In other words, the small companies will be forced to play the big game because they are being financed that way, even though that is not the main concern of their research.
Having read all the articles that accompanied this paper, and based upon the results of my own research readings, I will have to support the move to use taxpayer funding for the orphaned drugs and rare disorders research. The reason is quite simple, if the small pharmaceutical companies do not do it, who will? They honestly want to help that neglected portion of society but lack the means to do so. Then we should help them help those who cannot help themselves. It all boils down to a humanitarian act. Read More
Cite this document
  • APA
  • MLA
  • CHICAGO
(“Should we give tax breaks to companies developing drugs for rare Essay”, n.d.)
Retrieved from https://studentshare.org/biology/1583324-should-we-give-tax-breaks-to-companies-developing-drugs-for-rare-diseases
(Should We Give Tax Breaks to Companies Developing Drugs for Rare Essay)
https://studentshare.org/biology/1583324-should-we-give-tax-breaks-to-companies-developing-drugs-for-rare-diseases.
“Should We Give Tax Breaks to Companies Developing Drugs for Rare Essay”, n.d. https://studentshare.org/biology/1583324-should-we-give-tax-breaks-to-companies-developing-drugs-for-rare-diseases.
  • Cited: 0 times
Comments (0)
Click to create a comment or rate a document

CHECK THESE SAMPLES OF Should we give tax breaks to companies developing drugs for rare diseases

Rare Earth Minerals

...in the forms referred to us rare earth minerals. The question that we should asks ourselves, is why the united States hire and pay China to ship in these minerals to manufacture products such as missiles even though they are equally distributed across the globe? It should be noted, that most countries have little interest to mine and exploit these elements since they have several negative effects on the surrounding. One of the most dangerous wastes resulting from the exploitation of these minerals is the radioactive waste byproducts which many countries still can not handle (OECD Nuclear Energy Agency p37). This is the reason why the U.S. shut down its largest...
4 Pages(1000 words)Essay

Global companies tax avoidance and CSR

...been a missing element in the framework of CSR. CSR activities should also have tax obligations or compliance. Tax is portrayed as a cost, whereas it is a part of profit that is distributed back to stakeholders of the company. This reveals that the companies are not only generating revenue from investor’s capital but also from the funds of the society in which they operate. These funds are use for the development of the infrastructure of the country, growth of the society, education facilities, etc (Elkingtom, 1998) Companies like Google Inc, Amazon.com, etc were severely criticised for tax avoidance in...
12 Pages(3000 words)Essay

Tax Breaks as Spending

..., while the Republicans are only agreeing to reducing spending. Both the Democrats and Republicans agree that spending occurs in different ways for the government. “Congress and presidents of both parties long ago discovered that giving people a tax break – a deduction, credit, exclusion, or loophole – often makes them just as happy as giving them a check” (Wessel, 2013). The tax-break approach is been used by the government to hide the fact they are increasing their spending on the US economy. This strategy is referred to as backdoor spending through the tax code. Two of the major areas that are targeted by the...
3 Pages(750 words)Article

Social-multinational companies and developing countries

...in the last decade of 20th century when large scale implementation of these measures were initiated in Latin America and Asia with a declared good intention of bringing prosperity to native population. Here the whole issue is analyzed keeping in mind the spirit of natural justice and well being of the majority. Lenin stated, "The general framework of formally recognized free competition remains, and the yoke of a few monopolists on the population becomes a hundred times heavier, more burdensome and intolerable" (para 26). This statement puts in nutshell the whole issue of Multinational Companies and developing countries. To qualify to get loans from World Bank...
2 Pages(500 words)Essay

Rare Genetic Disease

...or retard the effect of progeria should have been briefly discussed.. Furthermore, A better understanding of the causes of this syndrome (Progeria) could lead to better insights into the mechanisms of both development and aging. Furthermore, the article emphasized that the cause of HGPS was identified in 2003,2 but failed to mention that progeria syndrome took its root as early as 1886 when Dr. Jonathan Hutchinson first described the disease.3 Certainly there are more studies available that might have served as a foundation to this article. One of those considered an authority in the study of HGPS is the Progeria Research Foundation (PRF). Following are some of the results from...
3 Pages(750 words)Essay

Marketing of Drugs, by Pharmaceutical Companies

...). Conclusion: The drug market is booming, and still the marketing practices of the pharmaceutical companies has seen a shift to the pursuit of maximizing profits, and this is to the detriment of the sick, who need their drugs. The full scope of the availability of newer drugs that is possible by greater concentration on research and development is missing, because of the over-emphasis on marketing. The ethics that were present in the marketing activities of the pharmaceutical companies have gradually eroded to the point of non-existence, and the marketing practices in current times give rise for concern, with the...
12 Pages(3000 words)Essay

Diseases

...up the microfilaria, which develop in the mosquito and gets passed on when the infected mosquito bites another individual. There is lack of clarity on how filariasis develops in the human body, but is generally believed that the infection occurs in early childhood, but manifests itself only in the adult stage due to the slow process of development of the disease. In lymphatic filariasis the filarial worms lodge themselves in the lymphatic system and cause inflammation in the lymphatic vessels. This leads to the overt manifestations of the disease in the form of enlargement of the entire arm or legs, genitals, vulva or breasts. As a result there is strong...
6 Pages(1500 words)Term Paper

Rare earth-Business Globalization

..., and by offering financial support to its domestic companies to invest in rare earth mines outside of China (Bloomberg Nov 11, 2010), (Bloomberg Oct 3,2010). USA and Japan, in a joint decision have agreed to diversify their rare earth suppliers in the face of mounting bilateral differences between the two Asian countries(The Japan Times Online).These developments have led to an international opinion being formed against China that it is wantonly indulging in brute arm-twisting tactics to misuse its monopoly over rare earths to settle old political issues with its historic rivals and to gate-crash uninvited into the high-tech club of the western...
7 Pages(1750 words)Research Paper

I.R.S. Plan to Uncover Companies Tax Strategies

...allowed the companies to keep any Uncertain Tax Position monies that weren’t audited within the three year statute of limitations. That was a lot of money for some of the major players, resulting in millions to billions of dollars in reserve “just in case”. For example Sheraton owner Starwood Hotels had almost a billion dollars in reserve, 21 per cent of its total 2009 earnings. The Fortune 500’s biggest companies like GM and Microsoft had reserves of $5.4 billion! Therefore if the corporations do business in the United States, they should be held to the same accountability as their employees are and pay Federal income tax at whatever rate they...
2 Pages(500 words)Essay

Diseases

...Diseases Diseases Location: Denmark Diseases listed: Escherichia coli diarrhea, Hepatitis A, Cholera, Toxoplasmosis and Lyme disease Details: Lyme disease is a bacterial infection that occurs throughout Denmark. According to a survey carried out by The Department of ecology, The Royal Veterinary and Agricultural University, the prevalence of Lyme disease in Denmark is approximately 4,98% (Matthews, 2012). The average number of infected nymphs during the assessment was approximately 3.0 per 100 m2 (Matthews, 2012). In addition, there was a correlation between the number of infected nymphs and the distribution in the number of Lyme...
2 Pages(500 words)Essay
sponsored ads
We use cookies to create the best experience for you. Keep on browsing if you are OK with that, or find out how to manage cookies.

Let us find you another Essay on topic Should we give tax breaks to companies developing drugs for rare diseases for FREE!

Contact Us